MicroRNA-127-3p controls murine hematopoietic stem cell maintenance by limiting differentiation.
Crisafulli L
Haematologica. 2019 Feb 21;104(9):1744-1755. doi: 10.3324/haematol.2018.198499
The new refined minnesota risk score for acute graft-versus-host disease predicts overall survival and non-relapse mortality after T cell-replete haploidentical stem cell transplant with post-transplant cyclophosphamide.
Mariotti J
Bone Marrow Transplant. 2019 Jan 24;54(7):1164-1167. doi: 10.1038/s41409-019-0453-0
Caspofungin for primary antifungal prophylaxis after T-cell-replete haploidentical stem cell transplantation with post-transplant cyclophosphamide.
Mariotti J
Eur J Haematol. 2019 Feb 13;102(4):357-367. doi: 10.1111/ejh.13214
Vascular amounts and dispersion of caliber-classified vessels as key parameters to quantitate 3D micro-angioarchitectures in multiple myeloma experimental tumors.
Righi M
Sci Rep. 2018 Nov 30;8(1):17520. doi: 10.1038/s41598-018-35788-4
A reduced dose of fluconazole as primary antifungal prophylaxis is not associated with increased risk of invasive fungal infections after allogeneic stem cell transplantation from a HLA identical sibling.
Sarina B
Transpl Infect Dis. 2018 May 16;20(4):e12906. doi: 10.1111/tid.12906
Genomic Integration of HHV-6 Mimicking Viral Reactivation after Autologous Stem Cell Transplantation.
Mineri R
Mediterr J Hematol Infect Dis. 2018 Feb 15;10(1):e2018013. doi: 10.4084/MJHID.2018.013
Are EBV-related and EBV-unrelated Hodgkin lymphomas different with regard to susceptibility to checkpoint blockade?
Carbone A, Gloghini A, Carlo-Stella C
Blood. 2018 May 1;132(1):17-22. doi: 10.1182/blood-2018-02-833806
Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma.
Spina V
Blood. 2018 Feb 15;131(22):2413-2425. doi: 10.1182/blood-2017-11-812073
Tandem autologous-haploidentical transplantation is a feasible and effective program for refractory Hodgkin lymphoma.
Mariotti J
Bone Marrow Transplant. 2017 Dec 21;53(3):366-370. doi: 10.1038/s41409-017-0032-1
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Mariotti J
Biol Blood Marrow Transplant. 2017 Nov 29;24(3):627-632. doi: 10.1016/j.bbmt.2017.11.030